Results 101 to 110 of about 60,143 (172)

Mesotelioma pleural secundario a radioterapia: una asociación infrecuente

Archivos de Bronconeumología, 2012
Leiro Fernández, Virginia, Fernández Villar, José Alberto, Lourido Cebreiro, Tamara   +2 more
openaire   +2 more sources

Malignant Pleural Mesothelioma: Analysis of 70 Cases in the Last Decade. [PDF]

Open Respir Arch
Garcia-Prieto F, Pardo SC, Ramírez MTR, Fernández AA.   +3 more
europepmc   +1 more source

Malignant Peritoneal Mesothelioma as a Rare Cause of Dyspeptic Complaints and Ascites: A Diagnostic Challenge. [PDF]

GE Port J Gastroenterol, 2020
Marques de Sousa S, Pereira F, Duarte M, Marques M, Vázquez D, Marques C.   +5 more
europepmc   +1 more source

Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights. [PDF]

Open Respir Arch
López-Castro R, Fuentes-Martín Á, Medina Del Valle A, García Peña T, Soro García J, López González L, Cilleruelo Ramos Á.   +6 more
europepmc   +1 more source

Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. [PDF]

Fam Cancer
Cerbone L, Perrino M, Grosso F, Ganzinelli M, Lo Russo G, Pasello G, Zucali PA, Ceresoli GL, Occhipinti M, Sculco M, on the behalf of MET-I (Mesothelioma team Italy).   +10 more
europepmc   +1 more source

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

BJS Open, 2021
Zahid A, Clarke L, Carr N, Chandrakumaran K, Tzivanakis A, Dayal S, Mohamed F, Cecil T, Moran BJ.   +8 more
europepmc   +1 more source

Mesotelioma peritoneal maligno en paciente sin exposición ocupacional. Reporte de un caso

, 2017
El mesotelioma peritoneal es un tumor maligno infrecuente que afecta más a mujeres, con una edad promedio de 53 años. El factor de riesgo más importante para desarrollar la enfermedad es la exposición crónica al asbesto, constituyéndose como una ...
Emmerick Rangel, Thadeu, Ortega Espinosa, César Ricardo, Saldarriaga Rivera, Lina María   +2 more
core  

Mesothelioma and Social Security Benefits in Brazil: 2019 to 2021. [PDF]

Rev Bras Med Trab
Gomes LEFE, Souza NSS.
europepmc   +1 more source

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis. [PDF]

J Cancer Res Clin Oncol, 2021
Carosio R, Fontana V, Mastracci L, Ferro P, Grillo F, Banelli B, Canessa PA, Dessanti P, Vigani A, Morabito A, Pfeffer U, Poggi A, Roncella S, Pistillo MP.   +13 more
europepmc   +1 more source